Mankind Pharma Limited Shareholders' Equity for the year ending March 31, 2025: USD 1.68 B

Mankind Pharma Limited Shareholders' Equity is USD 1.68 B for the year ending March 31, 2025, a 49.41% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Mankind Pharma Limited Shareholders' Equity for the year ending March 31, 2024 was USD 1.12 B, a 24.09% change year over year.
  • Mankind Pharma Limited Shareholders' Equity for the year ending March 31, 2023 was USD 904.64 M, a 11.60% change year over year.
  • Mankind Pharma Limited Shareholders' Equity for the year ending March 31, 2022 was USD 810.64 M, a 25.70% change year over year.
  • Mankind Pharma Limited Shareholders' Equity for the year ending March 31, 2021 was USD 644.88 M, a 39.43% change year over year.
Key Data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory